|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:BIRC6-EML6 (FusionGDB2 ID:9757) |
Fusion Gene Summary for BIRC6-EML6 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: BIRC6-EML6 | Fusion gene ID: 9757 | Hgene | Tgene | Gene symbol | BIRC6 | EML6 | Gene ID | 57448 | 400954 |
| Gene name | baculoviral IAP repeat containing 6 | EMAP like 6 | |
| Synonyms | APOLLON|BRUCE | - | |
| Cytomap | 2p22.3 | 2p16.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | baculoviral IAP repeat-containing protein 6BIR repeat-containing ubiquitin-conjugating enzymeRING-type E3 ubiquitin transferase BIRC6ubiquitin-conjugating BIR-domain enzyme apollon | echinoderm microtubule-associated protein-like 6EMAP-6echinoderm microtubule associated protein like 6 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q9NR09 | Q6ZMW3 | |
| Ensembl transtripts involved in fusion gene | ENST00000421745, | ENST00000490828, ENST00000356458, | |
| Fusion gene scores | * DoF score | 21 X 23 X 16=7728 | 6 X 6 X 4=144 |
| # samples | 33 | 6 | |
| ** MAII score | log2(33/7728*10)=-4.54955716458996 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/144*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: BIRC6 [Title/Abstract] AND EML6 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | BIRC6(32679010)-EML6(55071184), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across BIRC6 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across EML6 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PRAD | TCGA-KC-A4BL-01A | BIRC6 | chr2 | 32679010 | - | EML6 | chr2 | 55071184 | + |
Top |
Fusion Gene ORF analysis for BIRC6-EML6 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000421745 | ENST00000490828 | BIRC6 | chr2 | 32679010 | - | EML6 | chr2 | 55071184 | + |
| In-frame | ENST00000421745 | ENST00000356458 | BIRC6 | chr2 | 32679010 | - | EML6 | chr2 | 55071184 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000421745 | BIRC6 | chr2 | 32679010 | - | ENST00000356458 | EML6 | chr2 | 55071184 | + | 11840 | 4887 | 134 | 9916 | 3260 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000421745 | ENST00000356458 | BIRC6 | chr2 | 32679010 | - | EML6 | chr2 | 55071184 | + | 0.00038034 | 0.9996196 |
Top |
Fusion Genomic Features for BIRC6-EML6 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for BIRC6-EML6 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:32679010/chr2:55071184) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| BIRC6 | EML6 |
| FUNCTION: Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification. {ECO:0000269|PubMed:14765125, ECO:0000269|PubMed:15200957, ECO:0000269|PubMed:18329369}. | FUNCTION: May modify the assembly dynamics of microtubules, such that microtubules are slightly longer, but more dynamic. {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BIRC6 | chr2:32679010 | chr2:55071184 | ENST00000421745 | - | 23 | 74 | 30_36 | 1584 | 4858.0 | Compositional bias | Note=Poly-Ala |
| Hgene | BIRC6 | chr2:32679010 | chr2:55071184 | ENST00000421745 | - | 23 | 74 | 284_358 | 1584 | 4858.0 | Repeat | Note=BIR |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1355_1358 | 282 | 1959.0 | Compositional bias | Note=Poly-Lys | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1038_1077 | 282 | 1959.0 | Repeat | Note=WD 17 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1080_1120 | 282 | 1959.0 | Repeat | Note=WD 18 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1191_1230 | 282 | 1959.0 | Repeat | Note=WD 19 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1236_1276 | 282 | 1959.0 | Repeat | Note=WD 20 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1412_1456 | 282 | 1959.0 | Repeat | Note=WD 21 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1460_1501 | 282 | 1959.0 | Repeat | Note=WD 22 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1504_1543 | 282 | 1959.0 | Repeat | Note=WD 23 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1553_1591 | 282 | 1959.0 | Repeat | Note=WD 24 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1593_1638 | 282 | 1959.0 | Repeat | Note=WD 25 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1685_1724 | 282 | 1959.0 | Repeat | Note=WD 26 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1726_1767 | 282 | 1959.0 | Repeat | Note=WD 27 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1768_1807 | 282 | 1959.0 | Repeat | Note=WD 28 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1880_1919 | 282 | 1959.0 | Repeat | Note=WD 29 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 1925_1958 | 282 | 1959.0 | Repeat | Note=WD 30 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 280_321 | 282 | 1959.0 | Repeat | Note=WD 6 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 323_362 | 282 | 1959.0 | Repeat | Note=WD 7 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 364_403 | 282 | 1959.0 | Repeat | Note=WD 8 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 406_445 | 282 | 1959.0 | Repeat | Note=WD 9 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 561_601 | 282 | 1959.0 | Repeat | Note=WD 10 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 725_766 | 282 | 1959.0 | Repeat | Note=WD 11 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 770_811 | 282 | 1959.0 | Repeat | Note=WD 12 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 814_853 | 282 | 1959.0 | Repeat | Note=WD 13 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 861_900 | 282 | 1959.0 | Repeat | Note=WD 14 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 901_940 | 282 | 1959.0 | Repeat | Note=WD 15 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 996_1035 | 282 | 1959.0 | Repeat | Note=WD 16 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BIRC6 | chr2:32679010 | chr2:55071184 | ENST00000421745 | - | 23 | 74 | 1660_1668 | 1584 | 4858.0 | Compositional bias | Note=Poly-Ala |
| Hgene | BIRC6 | chr2:32679010 | chr2:55071184 | ENST00000421745 | - | 23 | 74 | 4573_4740 | 1584 | 4858.0 | Domain | UBC core |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 104_145 | 282 | 1959.0 | Repeat | Note=WD 2 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 148_187 | 282 | 1959.0 | Repeat | Note=WD 3 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 195_233 | 282 | 1959.0 | Repeat | Note=WD 4 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 235_273 | 282 | 1959.0 | Repeat | Note=WD 5 | |
| Tgene | EML6 | chr2:32679010 | chr2:55071184 | ENST00000356458 | 5 | 41 | 59_100 | 282 | 1959.0 | Repeat | Note=WD 1 |
Top |
Fusion Gene Sequence for BIRC6-EML6 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >9757_9757_1_BIRC6-EML6_BIRC6_chr2_32679010_ENST00000421745_EML6_chr2_55071184_ENST00000356458_length(transcript)=11840nt_BP=4887nt TCCCTGCTTCTCCCCCTCTCCCGTCAGCCTCCCTCCGAGTTTGGCCCCTCCGGCCGGGCGATCGACGTTCCGCGTGCGTGCGGGCGCCTG ACTTCACTTCCGGCTAACGCGCTCGGCTTGCCCCCTGGCCCCGGATGGTGACTGGTGGTGGTGCTGCACCTCCCGGGACTGTCACTGAGC CGCTTCCCAGTGTGATTGTGCTGAGCGCAGGCCGGAAGATGGCGGCTGCGGCTGCGGCGGCCTCGGGCCCCGGCTGCTCCTCGGCGGCGG GGGCGGGGGCGGCCGGGGTCTCAGAGTGGCTGGTGCTGCGGGACGGCTGCATGCACTGCGACGCCGACGGGCTGCACAGCCTGTCCTACC ACCCTGCGCTCAACGCCATCCTGGCCGTCACTAGCCGCGGGACCATCAAAGTCATCGACGGCACCTCGGGGGCCACACTGCAGGCCTCCG CGCTCAGTGCTAAACCAGGTGGACAGGTGAAATGTCAGTATATCTCTGCTGTGGATAAAGTTATATTTGTGGATGATTATGCAGTAGGGT GTAGGAAGGACCTTAATGGAATCTTGTTGTTAGACACTGCTCTGCAAACTCCAGTTTCAAAGCAGGATGATGTGGTTCAGCTTGAATTAC CCGTTACAGAGGCACAGCAGCTCTTATCAGCATGTTTAGAAAAGGTAGATATTTCTAGTACAGAGGGTTATGATTTGTTCATCACACAGC TCAAAGATGGTTTAAAAAATACATCTCATGAGACTGCAGCAAACCACAAAGTTGCTAAGTGGGCCACAGTTACATTTCATCTTCCTCATC ATGTGTTGAAGTCCATTGCCAGTGCCATTGTAAATGAACTCAAGAAAATAAATCAAAATGTTGCTGCCTTACCTGTGGCGTCCTCAGTGA TGGACAGATTGTCTTACCTCTTACCTAGTGCACGTCCAGAACTCGGAGTGGGGCCAGGCCGTTCTGTAGACAGATCACTGATGTATAGTG AAGCTAACAGACGGGAGACATTTACCTCATGGCCTCATGTAGGCTATAGGTGGGCACAACCAGATCCCATGGCTCAAGCTGGATTTTATC ATCAGCCTGCCTCATCTGGAGATGATAGAGCCATGTGTTTTACTTGTAGTGTATGCCTCGTTTGTTGGGAACCTACTGATGAACCTTGGT CTGAACACGAAAGACATTCCCCAAACTGCCCATTTGTGAAAGGTGAGCACACACAGAATGTGCCATTGTCAGTCACTCTTGCAACAAGTC CTGCACAGTTTCCTTGTACGGATGGAACTGACAGAATATCTTGCTTTGGGTCGGGGAGCTGCCCTCATTTTCTAGCTGCTGCAACTAAAC GAGGAAAGATCTGCATATGGGATGTTTCCAAACTTATGAAGGTGCACTTAAAGTTTGAAATTAATGCCTATGATCCAGCAATTGTACAAC AGCTTATTCTATCAGGAGACCCAAGCTCAGGAGTTGATTCAAGGAGACCAACTTTGGCGTGGCTGGAGGACTCCTCTAGTTGCTCAGATA TACCAAAATTGGAAGGAGATAGTGATGATTTACTGGAGGATTCAGACAGTGAAGAGCATTCCAGATCAGATTCTGTGACAGGGCATACAT CACAGAAGGAAGCCATGGAAGTAAGCCTTGATATAACAGCACTCAGCATTCTCCAACAGCCAGAAAAACTTCAGTGGGAGATTGTTGCAA ATGTGCTTGAAGATACTGTTAAGGATCTTGAAGAACTTGGGGCAAATCCTTGTTTAACAAACTCTAAGAGTGAAAAGACAAAGGAAAAGC ACCAGGAGCAACACAACATTCCTTTTCCATGTTTATTAGCTGGAGGTTTATTAACATATAAATCTCCTGCTACCTCACCCATTAGTAGTA ATTCTCACAGGTCACTGGATGGTTTAAGCAGAACTCAGGGTGAAAGTATATCAGAACAAGGGTCAACTGACAATGAATCCTGCACTAATT CAGAACTAAATTCTCCTCTGGTAAGGAGGACTTTACCGGTTTTGCTTCTTTATAGCATCAAGGAATCTGATGAGAAAGCAGGAAAGATCT TTTCACAGATGAACAATATTATGAGTAAAAGTTTGCATGATGATGGTTTTACTGTTCCACAGATTATTGAAATGGAGCTGGATAGTCAGG AGCAGTTGTTATTGCAGGATCCTCCTGTGACTTACATTCAGCAATTTGCAGATGCAGCAGCCAACCTTACCTCTCCGGATTCTGAGAAGT GGAACTCTGTGTTTCCCAAGCCTGGGACTTTGGTTCAGTGCTTGAGGCTGCCAAAGTTTGCAGAGGAGGAGAATCTTTGTATAGACTCAA TAACTCCTTGTGCTGACGGAATTCATTTGTTGGTAGGACTGCGGACATGCCCTGTTGAATCCTTGAGTGCAATAAATCAAGTAGAGGCCT TGAATAATTTAAATAAATTAAACTCTGCACTATGTAATAGACGGAAAGGTGAGCTGGAATCAAATCTTGCTGTAGTGAATGGTGCAAATA TTAGTGTAATCCAACATGAATCACCAGCAGATGTACAGACTCCTTTAATAATTCAGCCTGAGCAGAGGAATGTTAGTGGTGGATATTTAG TGCTTTATAAAATGAATTATGCCACTCGGATAGTGACTTTAGAAGAGGAGCCAATAAAAATACAACATATCAAAGATCCCCAGGACACAA TTACCTCGCTCATTTTGCTTCCACCCGATATATTGGATAATCGAGAGGATGACTGTGAGGAACCTATTGAGGACATGCAGTTAACCTCAA AGAATGGTTTTGAGAGAGAAAAAACGTCTGACATTTCTACTCTTGGACACCTGGTAATAACCACTCAGGGAGGATATGTAAAAATACTAG ATCTTTCAAACTTTGAAATTTTGGCCAAAGTGGAGCCTCCCAAAAAGGAGGGCACTGAGGAACAGGACACATTTGTTTCTGTGATTTACT GTTCTGGCACAGACAGGCTGTGTGCATGCACCAAAGGTGGTGAGCTTCATTTTCTCCAAATTGGAGGAACCTGTGATGATATTGATGAAG CTGATATACTAGTGGATGGATCTCTTTCTAAAGGAATAGAACCATCTTCAGAAGGTTCCAAACCTTTATCAAATCCTTCAAGTCCTGGCA TTTCAGGAGTTGATTTATTGGTGGACCAGCCATTCACCCTTGAAATCTTGACATCCCTAGTGGAGCTAACCCGCTTTGAGACTTTGACTC CAAGGTTTTCAGCGACTGTTCCTCCATGCTGGGTAGAAGTTCAACAAGAACAGCAGCAAAGGAGGCATCCTCAACATTTGCATCAGCAAC ACCATGGTGATGCTGCTCAGCATACTCGAACTTGGAAACTACAGACCGACAGCAACAGCTGGGATGAACATGTATTTGAATTAGTACTAC CTAAAGCTTGTATGGTTGGACATGTGGACTTCAAATTCGTTTTGAACTCAAACATCACCAATATTCCACAGATACAAGTGACACTGCTGA AAAATAAAGCTCCAGGATTAGGGAAAGTCAATGCTCTTAACATTGAAGTGGAACAAAATGGGAAACCGTCCCTGGTTGATTTGAATGAAG AAATGCAGCACATGGATGTAGAGGAATCACAGTGTCTTAGATTATGTCCATTTTTGGAGGATCATAAAGAAGACATTCTATGTGGGCCAG TATGGCTTGCTAGTGGCCTTGATCTATCAGGGCATGCTGGAATGTTGACGTTAACAAGCCCCAAACTTGTTAAAGGTATGGCAGGAGGAA AATATCGTTCGTTTTTAATCCATGTCAAGGCAGTGAATGAAAGAGGAACAGAAGAGATTTGTAATGGTGGTATGCGTCCTGTAGTAAGGC TTCCATCCCTAAAACACCAGAGTAACAAGGGTTATTCACTTGCTTCACTTTTGGCTAAAGTTGCAGCAGGCAAGGAAAAATCATCTAATG TTAAGAATGAAAATACAAGTGGCACCCGTAAATCTGAAAACCTCCGGGGCTGTGATTTACTTCAAGAGGTCTCAGTCACCATTCGAAGAT TTAAGAAAACCTCAATTTCTAAGGAAAGAGTGCAACGATGTGCCATGTTACAGTTTTCAGAATTTCATGAGAAGCTTGTTAATACTCTTT GCAGAAAAACAGATGATGGCCAGATCACAGAACATGCCCAGAGCCTTGTGTTGGATACTCTCTGTTGGTTAGCTGGAGTTCATTCAAATG GACCCGGAAGCTCAAAGGAAGGAAATGAGAACCTACTTTCAAAAACACGAAAATTTCTGTCAGACATCGTACGTGTTTGCTTCTTTGAGG CAGGACGAAGTATAGCCCATAAGTGTGCCCGATTTCTAGCCTTGTGCATTAGTAATGGCAAATGTGACCCATGTCAACCAGCATTTGGAC CTGTTCTGTTGAAGGCTTTACTTGATAATATGTCATTTTTACCTGCAGCAACAACTGGTGGTTCTGTCTATTGGTATTTTGTCTTACTGA ATTATGTGAAAGATGAAGATCTGGCTGGATGCAGTACAGCTTGTGCATCTTTGCTTACTGCAGTGTCCAGACAGTTACAGGACAGGCTAA CACCAATGGAGGCTTTACTTCAGACAAGATATGGATTATATAGCTCACCATTTGATCCAGTCCTCTTTGATTTGGAGATGAGTGGCTCTT CTTGTAAAAATGTTTATAACAGCAGCATTGGTGTCCAGTCAGATGAAATTGATTTATCAGATGTCCTTTCAGGAAATGGAAAGGTCAGTA GTTGCACAGCTGCTGAGGGTAGTTTCACATCTCTCACTGGACTTTTGGAAGTTGAACCTCTGCACTTTACTTGTGTGTCAACTAGTGATG GAACCAGAATAGAAAGGGATGATGCAAGCCTCTCTATCCGGAGCGTGTGCTGGAAAGCAGACCGCCTTCTAGCAGGGACCCAGGACAGTG AGATATTTGAAGTGATTGTGCGAGAGCGAGACAAGCCGATGTTGATCCTACAGGGCCACTGCGAGGGTGAGCTCTGGGCTCTGGCCCTGC ACCCCAAGAAGCCTCTGGCTGTGACAGGCAGCGATGACCGCTCTGTCAGGCTGTGGAGCCTGGCTGATCATGCCTTGATCGCCCGCTGTA ACATGGAAGAGGCGGTTCGCAGTGTAGCTTTCAGCCCCGACGGATCTCAGCTGGCCCTGGGCATGAAGGACGGCTCTTTCATTGTTCTCC GAGTCAGAGATATGACAGAAGTAGTTCACATCAAAGATCGAAAAGAAGTCATTCATGAAATGAAATTTTCTCCAGATGGTTCTTACCTTG CAGTGGGATCCAATGATGGCCCAGTAGATGTCTATGCTGTTGCCCAGAGGTATAAGAAAATTGGAGAATGCAGCAAGTCCCTTAGTTTCA TCACGCATATTGACTGGTCCTTGGATAGTAAATACTTACAAACTAATGACGGTGCAGGAGAACGATTGTTCTACAGAATGCCATCTGGGA AGCCTTTAACAAGTAAAGAAGAAATTAAAGGGATTCCTTGGGCCTCCTGGACATGCGTGAAAGGCCCTGAAGTGAGTGGAATTTGGCCCA AATACACTGAGGTTACTGACATCAACTCAGTGGATGCGAATTACAACAGCTCAGTGCTGGTGTCTGGAGATGATTTTGGACTGGTTAAAT TGTTTAAATTTCCTTGTCTCAAGAGAGGAGCCAAATTTAGAAAGTATGTGGGCCATTCTGCACATGTCACAAATGTCCGCTGGTCCCATG ACTTTCAGTGGGTGTTGAGCACAGGAGGGGCTGATCACTCAGTTTTCCAGTGGAGGTTTATTCCAGAAGGTGTCAGCAACGGCATGCTGG AAACTGCACCCCAAGAAGGTGGAGCTGATTCCTACAGTGAAGAATCTGATTCAGATTTATCTGATGTGCCCGAACTGGACTCTGATATTG AGCAAGAAGCTCAAATCAATTATGATCGCCAGGTTTACAAAGAAGATCTACCTCAGCTAAAGCAACAAAGTAAAGAGAAAAACCACGCAG TGCCCTTCCTCAAACGAGAAAAGGCTCCTGAGGACAGCTTGAAACTCCAGTTCATACACGGTTATAGAGGCTACGACTGTAGAAACAATC TGTTCTACACACAAGCTGGAGAAGTAGTCTACCACATTGCTGCAGTTGCTGTCGTGTATAATCGGCAGCAGCACTCCCAGAGGCTGTACC TGGGGCACGATGACGACATTCTCAGCCTGACCATCCATCCAGTGAAGGACTATGTGGCTACTGGGCAGGTTGGAAGAGATGCTGCTATTC ATGTGTGGGACACACAAACTCTAAAATGTTTGTCGCTGTTGAAAGGACAACATCAGAGAGGAGTGTGTGCACTTGATTTTTCAGCCGATG GAAAATGTCTGGTGTCGGTTGGTTTAGACGATTTTCACAGTATTGTATTTTGGGACTGGAAAAAGGGAGAAAAGATAGCCACAACAAGAG GACATAAAGATAAGATATTTGTGGTAAAGTGTAACCCACACCATGTTGACAAACTGGTTACAGTTGGGATAAAACACATCAAATTCTGGC AACAAGCAGGTGGGGGCTTCACTTCTAAAAGAGGAACTTTTGGAAGCGTTGGAAAATTGGAAACAATGATGTGTGTTTCTTACGGACGAA TGGAAGATCTAGTGTTCTCAGGAGCAGCTACTGGAGATATTTTTATTTGGAAAGACATTCTACTACTGAAGACAGTGAAAGCTCATGATG GGCCTGTGTTTGCTATGTATGCACTGGATAAGGGCTTTGTAACAGGTGGAAAGGACGGCATCGTGGAGCTCTGGGATGATATGTTTGAAA GATGTTTGAAGACTTATGCCATTAAAAGATCAGCATTGTCGACTAGCTCAAAAGGCTTGCTTTTGGAAGATAACCCTTCAATTCGTGCCA TCACTTTGGGACATGGACATATCCTGGTGGGAACAAAAAATGGAGAGATTCTGGAAATTGATAAGAGTGGCCCAATGACACTGCTTGTTC AGGGGCACATGGAAGGAGAAGTGTGGGGGTTGGCAGCTCACCCTCTCCTGCCCATCTGTGCAACAGTGAGCGATGATAAAACACTTCGCA TCTGGGAACTATCTGCCCAGCACCGTATGCTGGCAGTACGGAAACTCAAAAAAGGTGGAAGATGCTGTGCCTTTTCCCCTGATGGGAAAG CCTTAGCGGTTGGCTTGAACGATGGGAGTTTCCTGGTGGTAAATGCTGACACTGTTGAAGACATGGTCTCTTTCCATCACAGAAAAGAAA TGATCTCTGATATTAAGTTTTCAAAAGATACGGGAAAATACCTTGCCGTGGCATCCCATGATAACTTTGTGGATATTTACAACGTACTTA CAAGCAAAAGGGTTGGCATCTGTAAAGGTGCTTCTAGTTATATTACACACATTGACTGGGACTCTAGAGGAAAATTATTGCAAGTGAATT CAGGTGCCAGAGAACAACTTTTTTTTGAAGCTCCAAGAGGCAAACGGCATATAATAAGACCTTCAGAGATCGAGAAGATAGAGTGGGACA CATGGACCTGTGTCCTGGGGCCCACCTGTGAGGGAATCTGGCCAGCACATAGCGATATAACTGACGTAAATGCTGCCAGTCTTACCAAAG ACTGTTCCCTTTTAGCCACCGGAGATGATTTTGGTTTCGTTAAGCTTTTTTCATATCCTGTCAAGGGACAGCACGCAAGATTCAAGAAGT ATGTGGGGCACAGTGCACATGTCACTAACGTGAGGTGGCTGCACAATGACTCTGTGCTGCTCACGGTGGGCGGCGCCGACACAGCCCTGA TGATCTGGACCAGGGAGTTTGTGGGGACCCAGGAGAGCAAGCTGGTGGACAGCGAGGAGTCAGACACCGACGTGGAAGAGGATGGAGGCT ATGACAGCGATGTTGCTAGAGAAAAGGCCATTGACTACACCACCAAGATTTATGCTGTGAGCATCAGGGAAATGGAAGGCACCAAGCCAC ACCAGCAGCTGAAGGAAGTTTCCGTGGAAGAAAGACCACCCGTTAGCCGAGCAGCTCCCCAGCCTGAGAAACTGCAGAAGAACAATATCA CCAAAAAAAAGAAACTGGTTGAGGAGCTGGCTCTAGACCACGTGTTTGGCTACAGAGGTTTCGACTGTCGAAATAACCTGCATTACCTTA ATGATGGCGCTGACATCATCTTCCACACAGCAGCGGCTGGCATCGTTCAGAACCTCTCCACAGGGAGCCAGAGCTTCTATCTGGAGCACA CAGATGACATCCTCTGTCTCACAGTGAACCAGCACCCCAAGTACAGAAACGTGGTGGCCACCAGCCAGATAGGGACAACACCTTCCATCC ACATATGGGACGCCATGACCAAACACACCCTCTCCATGCTGCGGTGCTTCCACTCCAAGGGGGTGAATTACATCAACTTCAGTGCAACTG GAAAGCTCCTGGTGTCGGTGGGAGTGGACCCTGAGCACACCATCACTGTCTGGCGATGGCAGGAAGGTGCCAAGGTTGCCAGCCGAGGGG GTCACCTGGAGCGCATATTTGTGGTGGAATTTCGCCCCGACTCAGACACGCAGTTTGTATCTGTCGGGGTCAAACATATGAAGTTCTGGA CCCTGGCAGGCAGCGCCTTGCTTTACAAGAAAGGGGTCATCGGGTCCCTGGGAGCTGCCAAAATGCAGACGATGCTCTCCGTGGCCTTCG GTGCTAACAATCTCACTTTCACGGGTGCCATCAATGGAGATGTCTACGTCTGGAAGGACCACTTCCTCATCCGGCTGGTGGCCAAGGCTC ACACAGGCCCCGTGTTCACAATGTACACAACCCTTCGGGATGGACTCATAGTGACCGGCGGAAAAGAGAGGCCGACCAAAGAAGGAGGTG CTGTAAAATTGTGGGACCAGGAGATGAAGCGCTGCCGGGCCTTTCAGCTGGAGACCGGGCAGCTGGTGGAGTGTGTGCGCTCCGTGTGCC GTGGAAAAGGAAAAATCTTAGTGGGAACCAAAGACGGAGAAATAATTGAAGTTGGTGAAAAAAATGCTGCTTCTAACATCCTGATTGATG GTCACATGGAAGGGGAGATCTGGGGCCTGGCCACTCACCCTTCCAAGGACCTCTTCATCTCTGCCAGCAACGATGGCACAGCCCGGATCT GGGACCTGGCTGACAAGAAGCTGTTAAACAAGGTGAGCTTGGGCCATGCGGCCAGGTGTGCAGCCTACAGCCCTGATGGGGAGATGGTGG CCATTGGCATGAAGAATGGAGAGTTTGTCATCTTGTTGGTGAACAGCCTGAAAGTTTGGGGGAAAAAACGAGACCGGAAATCTGCTATCC AAGATATCAGAATCAGCCCAGACAACCGATTCTTAGCCGTTGGTTCTTCTGAACACACAGTTGACTTCTATGACCTCACTCAGGGCACAA ATCTGAACCGCATTGGCTACTGCAAAGATATCCCAAGCTTTGTCATTCAGATGGATTTTTCTGCGGATGGCAAATACATTCAGGTGTCAA CAGGTGCCTATAAGCGCCAGGTGCATGAGGTCCCCCTGGGGAAGCAGGTAACTGAAGCCGTGGTCATTGAGAAGATCACCTGGGCCTCCT GGACAAGCGTCCTGGGAGATGAAGTCATTGGAATCTGGCCACGAAATGCAGACAAGGCTGATGTCAACTGCGCATGTGTGACCCACGCTG GCCTGAACATTGTCACAGGAGATGACTTTGGGCTGGTGAAGCTCTTTGATTTTCCATGCACAGAAAAATTTGCCAAACATAAGCGATACT TCGGTCACTCGGCTCACGTGACGAACATCCGTTTCTCTTATGATGACAAGTATGTGGTCAGCACTGGAGGAGACGACTGCAGTGTATTTG TGTGGCGATGTCTGTAAAATGCCAGAAGCCTCTTATGTTATTGCTGCTGCTGCTACCAGCCAGCAACTGCAGAGGCCATGCTGAGGTGCC TCCTTGCCACCAGCCGTTGGGAAATGCCTACCATGCTGCCCCGGATGCACAAGCTCAAAACGCTGCAGAAGTTACACAACTGCTCCCATA ATCTGGACTCTCCAAAACCGTGATGCCACGAAGGAAGGTCAAGTTTTAAAATGTTAAAGACTGCTTGCCTCTGTTCCTGAGACTAAACAG TATACATACTAACTACATTGACAAAGAAATCCTATCTGATAATGTAGCCCGCTGACGAATTTTGAAGCCTCGGTTACCCTAACCAATATG TAGCTTTTAATTTGCATCAAAACTTTTACAAAGATGTTTTGCTATTGTTTCTATATACTTCAAGAATGTTCATTTTTACAAATAAGTTGA ACAAGACAGCCTAAGTTAGATGCACCGAAGTACTAGAAATATCGCTAGCCTCTGTTCTCCAGTTTAGCTTTCAAAACCAAATGAGCCATG TATAAAGGAGTTGAGAAACTTAATTTTTAAATGTTTCATTTGCAGAGTTTTATATCCATTAAGTGCCTTTGAAAGTTTCCAGTTGTGTGG GCTGCTGTCTCACCTCCCACCAATTTCTCCTTTCTCCATATGGTGCTAAAACCTCAAAGCTGAGGAGGGCTGCAGGACCCTTAGCAGATT CAGTGTGTCACCCTTGTCCTGTGTTCACGCCAAGGCTTCCTAAATGAAAGACATCGGTTACCTGCTTATGGGAAGGTGAGCAGCAAAGGA ATTGAAGTTCGGGACAGGGTAGAATTATGGGTTTTCATTGTGTTTCATGCCAAACCCACAAAATCCAAAATAGAATTCAAGTTAAACAAA CTTCTACTACAAAATGGAAGGGGAAAAAGGCTCAGGAAGGTCTATGAGAATGAGCTGACTTATCTCGTTAAATCTTAAGATAAATGAGGG TAACCCAAGGCTGCACCTTGGTGTACCACCCTGAGTGGAGTTGAGGTGACTTCATTTGATTGCTTCAGGCGAACTATATAGGTCAAGTCC AGATTATAAAAAAATTATCTGCAGAACAAATTGTAAACCCAAGGAATAGCTGGTAAATCAAAATTATAAAGTGAGTTAGAGTTCCTTGGA GTTGGTTGTATGACGGAATATGACTTGGACAATCTTTACCAGAAGCCATCCGTAAGCCCCTCAGTCACACTTTCCATGTAGCTGACCAGT GACTACAGGATGTGGCTGACAGTGCTCACTGAAAGGAGAGTTGGTGCGGGACTGGTGGTTCTGAGCACATAGACGCCTATTAGTCCTTCT GGTCAGTGAACGAAAATTCTAGACCTACAGTTACTGGCTACTTGCATTTGTCAGTTTAGAGAAAAGGTAAAATGAGGCATTTTCAATTGT AGAATAGACTAACATTTACCACAGAAGTGCTTCAGCATTCTAAATGGATTAGATCACTCATTAAGCTATTTTTATATGCCAATTTACTAA TGCCTTACATCAATCCACTAATAGGTTGTTGGGCCCGCAGTAGAGTCCCTATGCAGTCCCAATTCTGTTTTCTGTAACCATGTGACTGGT GATGCAGAGTGATAACCATGTCTGCCTATCTTGTACTAGACTCTTCATGCTGATCGGATCTTGCATTGAAATAACCATGTGGAAGAACAA TGAATCGATTAATGATGACATGTACAACCATATTTAAAGAGCAATAGTGTCCGTGTGTCATGAAAAACTTATTTGTAAACGTTTATATGG TATGATTTTGATTTTATGTATGTTCATAAATCCTGCACTGTATGATATATGTGAGTTAAAACATTGGTGCATGAATTTATTTTCAAAGTA >9757_9757_1_BIRC6-EML6_BIRC6_chr2_32679010_ENST00000421745_EML6_chr2_55071184_ENST00000356458_length(amino acids)=3260AA_BP=1849 MVTGGGAAPPGTVTEPLPSVIVLSAGRKMAAAAAAASGPGCSSAAGAGAAGVSEWLVLRDGCMHCDADGLHSLSYHPALNAILAVTSRGT IKVIDGTSGATLQASALSAKPGGQVKCQYISAVDKVIFVDDYAVGCRKDLNGILLLDTALQTPVSKQDDVVQLELPVTEAQQLLSACLEK VDISSTEGYDLFITQLKDGLKNTSHETAANHKVAKWATVTFHLPHHVLKSIASAIVNELKKINQNVAALPVASSVMDRLSYLLPSARPEL GVGPGRSVDRSLMYSEANRRETFTSWPHVGYRWAQPDPMAQAGFYHQPASSGDDRAMCFTCSVCLVCWEPTDEPWSEHERHSPNCPFVKG EHTQNVPLSVTLATSPAQFPCTDGTDRISCFGSGSCPHFLAAATKRGKICIWDVSKLMKVHLKFEINAYDPAIVQQLILSGDPSSGVDSR RPTLAWLEDSSSCSDIPKLEGDSDDLLEDSDSEEHSRSDSVTGHTSQKEAMEVSLDITALSILQQPEKLQWEIVANVLEDTVKDLEELGA NPCLTNSKSEKTKEKHQEQHNIPFPCLLAGGLLTYKSPATSPISSNSHRSLDGLSRTQGESISEQGSTDNESCTNSELNSPLVRRTLPVL LLYSIKESDEKAGKIFSQMNNIMSKSLHDDGFTVPQIIEMELDSQEQLLLQDPPVTYIQQFADAAANLTSPDSEKWNSVFPKPGTLVQCL RLPKFAEEENLCIDSITPCADGIHLLVGLRTCPVESLSAINQVEALNNLNKLNSALCNRRKGELESNLAVVNGANISVIQHESPADVQTP LIIQPEQRNVSGGYLVLYKMNYATRIVTLEEEPIKIQHIKDPQDTITSLILLPPDILDNREDDCEEPIEDMQLTSKNGFEREKTSDISTL GHLVITTQGGYVKILDLSNFEILAKVEPPKKEGTEEQDTFVSVIYCSGTDRLCACTKGGELHFLQIGGTCDDIDEADILVDGSLSKGIEP SSEGSKPLSNPSSPGISGVDLLVDQPFTLEILTSLVELTRFETLTPRFSATVPPCWVEVQQEQQQRRHPQHLHQQHHGDAAQHTRTWKLQ TDSNSWDEHVFELVLPKACMVGHVDFKFVLNSNITNIPQIQVTLLKNKAPGLGKVNALNIEVEQNGKPSLVDLNEEMQHMDVEESQCLRL CPFLEDHKEDILCGPVWLASGLDLSGHAGMLTLTSPKLVKGMAGGKYRSFLIHVKAVNERGTEEICNGGMRPVVRLPSLKHQSNKGYSLA SLLAKVAAGKEKSSNVKNENTSGTRKSENLRGCDLLQEVSVTIRRFKKTSISKERVQRCAMLQFSEFHEKLVNTLCRKTDDGQITEHAQS LVLDTLCWLAGVHSNGPGSSKEGNENLLSKTRKFLSDIVRVCFFEAGRSIAHKCARFLALCISNGKCDPCQPAFGPVLLKALLDNMSFLP AATTGGSVYWYFVLLNYVKDEDLAGCSTACASLLTAVSRQLQDRLTPMEALLQTRYGLYSSPFDPVLFDLEMSGSSCKNVYNSSIGVQSD EIDLSDVLSGNGKVSSCTAAEGSFTSLTGLLEVEPLHFTCVSTSDGTRIERDDASLSIRSVCWKADRLLAGTQDSEIFEVIVRERDKPML ILQGHCEGELWALALHPKKPLAVTGSDDRSVRLWSLADHALIARCNMEEAVRSVAFSPDGSQLALGMKDGSFIVLRVRDMTEVVHIKDRK EVIHEMKFSPDGSYLAVGSNDGPVDVYAVAQRYKKIGECSKSLSFITHIDWSLDSKYLQTNDGAGERLFYRMPSGKPLTSKEEIKGIPWA SWTCVKGPEVSGIWPKYTEVTDINSVDANYNSSVLVSGDDFGLVKLFKFPCLKRGAKFRKYVGHSAHVTNVRWSHDFQWVLSTGGADHSV FQWRFIPEGVSNGMLETAPQEGGADSYSEESDSDLSDVPELDSDIEQEAQINYDRQVYKEDLPQLKQQSKEKNHAVPFLKREKAPEDSLK LQFIHGYRGYDCRNNLFYTQAGEVVYHIAAVAVVYNRQQHSQRLYLGHDDDILSLTIHPVKDYVATGQVGRDAAIHVWDTQTLKCLSLLK GQHQRGVCALDFSADGKCLVSVGLDDFHSIVFWDWKKGEKIATTRGHKDKIFVVKCNPHHVDKLVTVGIKHIKFWQQAGGGFTSKRGTFG SVGKLETMMCVSYGRMEDLVFSGAATGDIFIWKDILLLKTVKAHDGPVFAMYALDKGFVTGGKDGIVELWDDMFERCLKTYAIKRSALST SSKGLLLEDNPSIRAITLGHGHILVGTKNGEILEIDKSGPMTLLVQGHMEGEVWGLAAHPLLPICATVSDDKTLRIWELSAQHRMLAVRK LKKGGRCCAFSPDGKALAVGLNDGSFLVVNADTVEDMVSFHHRKEMISDIKFSKDTGKYLAVASHDNFVDIYNVLTSKRVGICKGASSYI THIDWDSRGKLLQVNSGAREQLFFEAPRGKRHIIRPSEIEKIEWDTWTCVLGPTCEGIWPAHSDITDVNAASLTKDCSLLATGDDFGFVK LFSYPVKGQHARFKKYVGHSAHVTNVRWLHNDSVLLTVGGADTALMIWTREFVGTQESKLVDSEESDTDVEEDGGYDSDVAREKAIDYTT KIYAVSIREMEGTKPHQQLKEVSVEERPPVSRAAPQPEKLQKNNITKKKKLVEELALDHVFGYRGFDCRNNLHYLNDGADIIFHTAAAGI VQNLSTGSQSFYLEHTDDILCLTVNQHPKYRNVVATSQIGTTPSIHIWDAMTKHTLSMLRCFHSKGVNYINFSATGKLLVSVGVDPEHTI TVWRWQEGAKVASRGGHLERIFVVEFRPDSDTQFVSVGVKHMKFWTLAGSALLYKKGVIGSLGAAKMQTMLSVAFGANNLTFTGAINGDV YVWKDHFLIRLVAKAHTGPVFTMYTTLRDGLIVTGGKERPTKEGGAVKLWDQEMKRCRAFQLETGQLVECVRSVCRGKGKILVGTKDGEI IEVGEKNAASNILIDGHMEGEIWGLATHPSKDLFISASNDGTARIWDLADKKLLNKVSLGHAARCAAYSPDGEMVAIGMKNGEFVILLVN SLKVWGKKRDRKSAIQDIRISPDNRFLAVGSSEHTVDFYDLTQGTNLNRIGYCKDIPSFVIQMDFSADGKYIQVSTGAYKRQVHEVPLGK QVTEAVVIEKITWASWTSVLGDEVIGIWPRNADKADVNCACVTHAGLNIVTGDDFGLVKLFDFPCTEKFAKHKRYFGHSAHVTNIRFSYD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for BIRC6-EML6 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for BIRC6-EML6 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for BIRC6-EML6 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies